Abstract
Several articles in this month's issue of the Journal advance what is known about attention-deficit/hyperactivity disorder (ADHD). Articles by Molina et al. ( p. 484 ) and Jensen et al. ( p. 501 ) provide new analyses of the landmark NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA). In the original MTA study, 579 children between 7 and 9.9 years old were randomized to 14 months of either systematic medication management with methylphenidate, multicomponent behavior therapy, combined medication plus behavior therapy, or community care.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
